Literature DB >> 20210929

Expression of growth differentiation factor 15 is not elevated in individuals with iron deficiency secondary to volunteer blood donation.

Toshihiko Tanno1, Antoinette Rabel, Y Terry Lee, Yu Ying Yau, Susan F Leitman, Jeffery L Miller.   

Abstract

BACKGROUND: Low serum hepcidin levels provide a physiologic response to iron demand in patients with iron deficiency (ID). Based on a discovery of suppressed hepcidin expression by a cytokine named growth differentiation factor 15 (GDF15), it was hypothesized that GDF15 may suppress hepcidin expression in humans with ID due to blood loss. STUDY DESIGN AND METHODS: To test this hypothesis, GDF15 and hepcidin levels were measured in peripheral blood from subjects with iron-deficient erythropoiesis before and after iron supplementation.
RESULTS: Iron variables and hepcidin levels were significantly suppressed in iron-deficient blood donors compared to healthy volunteers. However, ID was not associated with elevated serum levels of GDF15. Instead, iron-deficient subjects' GDF15 levels were slightly lower than those measured in the control group of subjects (307 +/- 90 and 386 +/- 104 pg/mL, respectively). Additionally, GDF15 levels were not significantly altered by iron repletion.
CONCLUSIONS: ID due to blood loss is not associated with a significant change in serum levels of GDF15.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20210929      PMCID: PMC3282986          DOI: 10.1111/j.1537-2995.2010.02601.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  10 in total

1.  A p53-type response element in the GDF15 promoter confers high specificity for p53 activation.

Authors:  Motonobu Osada; Hannah Lui Park; Min Joo Park; Jun-Wei Liu; Guojun Wu; Barry Trink; David Sidransky
Journal:  Biochem Biophys Res Commun       Date:  2007-01-25       Impact factor: 3.575

2.  Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications.

Authors:  Erwin H J M Kemna; Harold Tjalsma; Vladimir N Podust; Dorine W Swinkels
Journal:  Clin Chem       Date:  2007-02-01       Impact factor: 8.327

3.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Authors:  Gaël Nicolas; Caroline Chauvet; Lydie Viatte; Jean Louis Danan; Xavier Bigard; Isabelle Devaux; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

4.  Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.

Authors:  Hannah Tamary; Hanna Shalev; Galit Perez-Avraham; Meira Zoldan; Itai Levi; Dorine W Swinkels; Toshihiko Tanno; Jeffery L Miller
Journal:  Blood       Date:  2008-09-29       Impact factor: 22.113

5.  Regulation of growth differentiation factor 15 expression by intracellular iron.

Authors:  Samira Lakhal; Nick P Talbot; Alexi Crosby; Chantal Stoepker; Alain R M Townsend; Peter A Robbins; Christopher W Pugh; Peter J Ratcliffe; David R Mole
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

6.  Immunoassay for human serum hepcidin.

Authors:  Tomas Ganz; Gordana Olbina; Domenico Girelli; Elizabeta Nemeth; Mark Westerman
Journal:  Blood       Date:  2008-08-08       Impact factor: 22.113

7.  High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.

Authors:  Toshihiko Tanno; Natarajan V Bhanu; Patricia A Oneal; Sung-Ho Goh; Pamela Staker; Y Terry Lee; John W Moroney; Christopher H Reed; Naomi L C Luban; Rui-Hong Wang; Thomas E Eling; Richard Childs; Tomas Ganz; Susan F Leitman; Suthat Fucharoen; Jeffery L Miller
Journal:  Nat Med       Date:  2007-08-26       Impact factor: 53.440

8.  Behavioral, biochemical, and genetic analysis of iron metabolism in high-intensity blood donors.

Authors:  Alan E Mast; Tisha M Foster; Holly L Pinder; Craig A Beczkiewicz; Daniel B Bellissimo; Anthony T Murphy; Steve Kovacevic; Victor J Wroblewski; Derrick R Witcher
Journal:  Transfusion       Date:  2008-07-24       Impact factor: 3.157

Review 9.  Iron regulation and erythropoiesis.

Authors:  Elizabeta Nemeth
Journal:  Curr Opin Hematol       Date:  2008-05       Impact factor: 3.284

10.  Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha.

Authors:  Jorge P Pinto; Sara Ribeiro; Helena Pontes; Shifaan Thowfeequ; David Tosh; Félix Carvalho; Graça Porto
Journal:  Blood       Date:  2008-03-07       Impact factor: 22.113

  10 in total
  18 in total

Review 1.  Hepcidin and iron homeostasis.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Biochim Biophys Acta       Date:  2012-01-26

Review 2.  Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.

Authors:  Sara Gardenghi; Robert W Grady; Stefano Rivella
Journal:  Hematol Oncol Clin North Am       Date:  2010-10-15       Impact factor: 3.722

3.  Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice.

Authors:  Huihui Li; Tenzin Choesang; Weili Bao; Huiyong Chen; Maria Feola; Daniel Garcia-Santos; Jie Li; Shuming Sun; Antonia Follenzi; Petra Pham; Jing Liu; Jinghua Zhang; Prem Ponka; Xiuli An; Narla Mohandas; Robert E Fleming; Stefano Rivella; Guiyuan Li; Yelena Z Ginzburg
Journal:  Blood       Date:  2017-02-01       Impact factor: 22.113

Review 4.  Regulation of erythropoiesis by hypoxia-inducible factors.

Authors:  Volker H Haase
Journal:  Blood Rev       Date:  2013-01-03       Impact factor: 8.250

5.  Evidence that the expression of transferrin receptor 1 on erythroid marrow cells mediates hepcidin suppression in the liver.

Authors:  Siobán B Keel; Raymond Doty; Li Liu; Elizabeta Nemeth; Sindhu Cherian; Tomas Ganz; Janis L Abkowitz
Journal:  Exp Hematol       Date:  2015-03-14       Impact factor: 3.084

Review 6.  Hepcidin and iron regulation, 10 years later.

Authors:  Tomas Ganz
Journal:  Blood       Date:  2011-02-23       Impact factor: 22.113

7.  Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice.

Authors:  Chia-Yu Wang; Amanda B Core; Susanna Canali; Kimberly B Zumbrennen-Bullough; Sinan Ozer; Lieve Umans; An Zwijsen; Jodie L Babitt
Journal:  Blood       Date:  2017-04-24       Impact factor: 22.113

Review 8.  Iron deficiency anemia: a common and curable disease.

Authors:  Jeffery L Miller
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

9.  Hepcidin/Ferritin Quotient Helps to Predict Spontaneous Recovery from Iron Loss following Blood Donation.

Authors:  Ramin Lotfi; Christine Kroll; Dietmar Plonné; Bernd Jahrsdörfer; Hubert Schrezenmeier
Journal:  Transfus Med Hemother       Date:  2015-11-03       Impact factor: 3.747

Review 10.  Molecular liaisons between erythropoiesis and iron metabolism.

Authors:  Leon Kautz; Elizabeta Nemeth
Journal:  Blood       Date:  2014-05-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.